{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:39:44Z","timestamp":1790174384618,"version":"4.1.0"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"10","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The translocation t(11;18)(q21;q21) that generates an API2-MALT1 fusion protein is the most common structural abnormality among the genetic defects reported in mucosa-associated lymphoid tissue (MALT)-type lymphomas, and its presence correlates with the apparent lack of further genetic instability or chromosomal imbalances. Hence, constitutive nuclear factor-\u03baB (NF-\u03baB) activation induced by the API2-MALT1 fusion protein is considered essential for B-cell transformation. To examine its role in B-cell development and lymphomagenesis, E\u03bc-API2-MALT1 transgenic mice were produced. Our data show that expression of the API2-MALT1 fusion protein alone is not sufficient for the development of lymphoma masses within 50 weeks. Nevertheless, API2-MALT1 expression affected B-cell maturation in the bone marrow and triggered the specific expansion of splenic marginal zone B cells. Polyubiquitination of I\u03baB kinase \u03b3 (IKK\u03b3), indicative for enhanced NF-\u03baB activation, was increased in splenic lymphocytes and promoted the survival of B cells ex vivo. In addition, we show that the API2-MALT1 fusion resided in the cholesterol- and sphingolipid-enriched membrane microdomains, termed lipid rafts. We provide evidence that association of the MALT1 COOH terminal with the lipid rafts, which is mediated by the API2 portion, is sufficient to trigger NF-\u03baB activation via enhanced polyubiquitination of IKK\u03b3. Taken together, these data support the hypothesis that the API2-MALT1 fusion protein can contribute to MALT lymphoma formation via increased NF-\u03baB activation. (Cancer Res 2006; 66(10): 5270-7)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-4590","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T22:47:01Z","timestamp":1147819621000},"page":"5270-5277","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Selective Expansion of Marginal Zone B Cells in E\u03bc-API2-MALT1 Mice Is Linked to Enhanced I\u03baB Kinase \u03b3 Polyubiquitination"],"prefix":"10.1158","volume":"66","author":[{"given":"Mathijs","family":"Baens","sequence":"first","affiliation":[{"name":"1Center for Human Genetics, Molecular Genetics, Flanders Interuniversity Institute for Biotechnology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Fevery","sequence":"additional","affiliation":[{"name":"2Laboratory of Experimental Transplantation and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Sagaert","sequence":"additional","affiliation":[{"name":"3Division of Morphology and Molecular Pathology, Catholic University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Noels","sequence":"additional","affiliation":[{"name":"1Center for Human Genetics, Molecular Genetics, Flanders Interuniversity Institute for Biotechnology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Hagens","sequence":"additional","affiliation":[{"name":"1Center for Human Genetics, Molecular Genetics, Flanders Interuniversity Institute for Biotechnology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Broeckx","sequence":"additional","affiliation":[{"name":"1Center for Human Genetics, Molecular Genetics, Flanders Interuniversity Institute for Biotechnology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An D.","family":"Billiau","sequence":"additional","affiliation":[{"name":"2Laboratory of Experimental Transplantation and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"De Wolf-Peeters","sequence":"additional","affiliation":[{"name":"3Division of Morphology and Molecular Pathology, Catholic University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Marynen","sequence":"additional","affiliation":[{"name":"1Center for Human Genetics, Molecular Genetics, Flanders Interuniversity Institute for Biotechnology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,5,16]]},"reference":[{"key":"2022061621042586000_B1","doi-asserted-by":"crossref","unstructured":"Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood\u20081999; 93: 3601\u20139.","DOI":"10.1182\/blood.V93.11.3601.411a47_3601_3609"},{"key":"2022061621042586000_B2","doi-asserted-by":"crossref","unstructured":"Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell\u20081999; 96: 35\u201345.","DOI":"10.1016\/S0092-8674(00)80957-5"},{"key":"2022061621042586000_B3","doi-asserted-by":"crossref","unstructured":"Zhang Q, Siebert R, Yan M, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet\u20081999; 22: 63\u20138.","DOI":"10.1038\/8767"},{"key":"2022061621042586000_B4","doi-asserted-by":"crossref","unstructured":"Streubel A, Lamprecht A, Dierlamm J, et al. t(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood\u20082003; 101: 2335\u20139.","DOI":"10.1182\/blood-2002-09-2963"},{"key":"2022061621042586000_B5","doi-asserted-by":"crossref","unstructured":"Sanchez-Izquierdo D, Buchonnet G, Siebert R, et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood\u20082003; 101: 4539\u201346.","DOI":"10.1182\/blood-2002-10-3236"},{"key":"2022061621042586000_B6","doi-asserted-by":"crossref","unstructured":"Ruland J, Duncan GS, Elia A, et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-\u03baB and neural tube closure. Cell\u20082001; 104: 33\u201342.","DOI":"10.1016\/S0092-8674(01)00189-1"},{"key":"2022061621042586000_B7","doi-asserted-by":"crossref","unstructured":"Ruland J, Duncan GS, Wakeham A, Mak TW. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity\u20082003; 19: 749\u201358.","DOI":"10.1016\/S1074-7613(03)00293-0"},{"key":"2022061621042586000_B8","doi-asserted-by":"crossref","unstructured":"Ruefli-Brasse AA, French DM, Dixit VM. Regulation of NF-\u03baB-dependent lymphocyte activation and development by paracaspase. Science\u20082003; 302: 1581\u20134.","DOI":"10.1126\/science.1090769"},{"key":"2022061621042586000_B9","doi-asserted-by":"crossref","unstructured":"Uren GA, O'Rourke K, Aravind L, et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell\u20082000; 6: 961\u20137.","DOI":"10.1016\/S1097-2765(00)00094-0"},{"key":"2022061621042586000_B10","doi-asserted-by":"crossref","unstructured":"Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-\u03baB signaling pathway. J Biol Chem\u20082001; 276: 19012\u20139.","DOI":"10.1074\/jbc.M009984200"},{"key":"2022061621042586000_B11","doi-asserted-by":"crossref","unstructured":"Sun LJ, Deng L, Ea CK, Xia ZP, Chen ZJJ. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell\u20082004; 14: 289\u2013301.","DOI":"10.1016\/S1097-2765(04)00236-9"},{"key":"2022061621042586000_B12","doi-asserted-by":"crossref","unstructured":"Zhou HL, Du MQ, Dixit VM. Constitutive NF-\u03baB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell\u20082005; 7: 425\u201331.","DOI":"10.1016\/j.ccr.2005.04.012"},{"key":"2022061621042586000_B13","doi-asserted-by":"crossref","unstructured":"Wang D, You Y, Case SM, et al. A requirement for CARMA1 in TCR-induced NF-\u03baB activation. Nat Immunol\u20082002; 3: 830\u20135.","DOI":"10.1038\/ni824"},{"key":"2022061621042586000_B14","doi-asserted-by":"crossref","unstructured":"Gaide O, Favier B, Legler DF, et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-\u03baB activation. Nat Immunol\u20082002; 3: 836\u201343.","DOI":"10.1038\/ni830"},{"key":"2022061621042586000_B15","doi-asserted-by":"crossref","unstructured":"Wang D, Matsumoto R, You Y, et al. CD3\/CD28 costimulation-induced NF-\u03baB activation is mediated by recruitment of protein kinase C-\ud835\udec9, Bcl10, and I\u03baB kinase \u03b2 to the immunological synapse through CARMA1. Mol Cell Biol\u20082004; 24: 164\u201371.","DOI":"10.1128\/MCB.24.1.164-171.2003"},{"key":"2022061621042586000_B16","doi-asserted-by":"crossref","unstructured":"Che TJ, You Y, Wang DH, Tanner MJ, Dixit VM, Lin X. MALT1\/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-\u03baB activation. J Biol Chem\u20082004; 279: 15870\u20136.","DOI":"10.1074\/jbc.M310599200"},{"key":"2022061621042586000_B17","doi-asserted-by":"crossref","unstructured":"Ho L, Davis RE, Conne B, et al. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-\u03baB-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood\u20082005; 105: 2891\u20139.","DOI":"10.1182\/blood-2004-06-2297"},{"key":"2022061621042586000_B18","doi-asserted-by":"crossref","unstructured":"Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J\u20081994; 13: 2124\u201330.","DOI":"10.1002\/j.1460-2075.1994.tb06488.x"},{"key":"2022061621042586000_B19","doi-asserted-by":"crossref","unstructured":"Brinster RL, Chen HY, Trumbauer M, Senear AW, Warren R, Palmiter RD. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell\u20081981; 27: 223\u201331.","DOI":"10.1016\/0092-8674(81)90376-7"},{"key":"2022061621042586000_B20","doi-asserted-by":"crossref","unstructured":"Heyninck K, De Valck D, Vanden Berghe W, et al. The zinc finger protein A20 inhibits TNF-induced NF-\u03baB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-\u03baB-inhibiting protein ABIN. J Cell Biol\u20081999; 145: 1471\u201382.","DOI":"10.1083\/jcb.145.7.1471"},{"key":"2022061621042586000_B21","doi-asserted-by":"crossref","unstructured":"Liu HX, Ye HT, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H-pylori eradication. Gastroenterology\u20082002; 122: 1286\u201394.","DOI":"10.1053\/gast.2002.33047"},{"key":"2022061621042586000_B22","doi-asserted-by":"crossref","unstructured":"Li YS, Wasserman R, Hayakawa K, Hardy RR. Identification of the earliest B lineage stage in mouse bone marrow. Immunity\u20081996; 5: 527\u201335.","DOI":"10.1016\/S1074-7613(00)80268-X"},{"key":"2022061621042586000_B23","doi-asserted-by":"crossref","unstructured":"Ye H, Dogan A, Karran L, et al. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am J Pathol\u20082000; 157: 1147\u201354.","DOI":"10.1016\/S0002-9440(10)64630-5"},{"key":"2022061621042586000_B24","doi-asserted-by":"crossref","unstructured":"Liu HX, Ye HT, Dogan A, et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood\u20082001; 98: 1182\u20137.","DOI":"10.1182\/blood.V98.4.1182"},{"key":"2022061621042586000_B25","doi-asserted-by":"crossref","unstructured":"Maes B, Demunter A, Peeters B, Wolf-Peeters C. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood\u20082002; 99: 1398\u2013404.","DOI":"10.1182\/blood.V99.4.1398"},{"key":"2022061621042586000_B26","doi-asserted-by":"crossref","unstructured":"Ye H, Liu H, Raderer M, et al. High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood\u20082003; 101: 2547\u201350.","DOI":"10.1182\/blood-2002-10-3167"},{"key":"2022061621042586000_B27","doi-asserted-by":"crossref","unstructured":"Gugasyan R, Grumont R, Grossmann M, et al. Rel\/NF-\u03baB transcription factors: key mediators of B-cell activation. Immunol Rev\u20082000; 176: 134\u201340.","DOI":"10.1034\/j.1600-065X.2000.00615.x"},{"key":"2022061621042586000_B28","doi-asserted-by":"crossref","unstructured":"Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT lymphomas. Hematology (Am Soc Hematol Educ Program) 2001;241\u201358.","DOI":"10.1182\/asheducation-2001.1.241"},{"key":"2022061621042586000_B29","unstructured":"Strasser A, Harris AW, Cory S. E\u03bc-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T-cells. Oncogene\u20081993; 8: 1\u20139."},{"key":"2022061621042586000_B30","doi-asserted-by":"crossref","unstructured":"Nakagawa M, Hosokawa Y, Yonezumi M, et al. MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10. Blood\u20082005; 106: 4210\u20136.","DOI":"10.1182\/blood-2004-12-4785"},{"key":"2022061621042586000_B31","doi-asserted-by":"crossref","unstructured":"Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer\u20082004; 4: 644\u201353.","DOI":"10.1038\/nrc1409"},{"key":"2022061621042586000_B32","unstructured":"Zhang Q, Cui X, Sangster MY, et al. Selective hyperexpansion of marginal zone (MZ) B-cells in E\u03bc-BCL10 mice. Blood\u20082000; 96: 822A."},{"key":"2022061621042586000_B33","doi-asserted-by":"crossref","unstructured":"Pillai S, Cariappa A, Moran ST. Marginal zone B cells. Annu Rev Immunol\u20082005; 23: 161\u201396.","DOI":"10.1146\/annurev.immunol.23.021704.115728"},{"key":"2022061621042586000_B34","doi-asserted-by":"crossref","unstructured":"Namen AE, Schmierer AE, March CJ, et al. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med\u20081988; 167: 988\u20131002.","DOI":"10.1084\/jem.167.3.988"},{"key":"2022061621042586000_B35","doi-asserted-by":"crossref","unstructured":"Smart FM, Venkitaraman AR. Inhibition of interleukin 7 receptor signaling by antigen receptor assembly. J Exp Med\u20082000; 191: 737\u201342.","DOI":"10.1084\/jem.191.4.737"},{"key":"2022061621042586000_B36","doi-asserted-by":"crossref","unstructured":"Siebenlist U, Brown K, Claudio E. Control of lymphocyte development by nuclear factor-\u03baB. Nat Rev Immunol\u20082005; 5: 435\u201345.","DOI":"10.1038\/nri1629"},{"key":"2022061621042586000_B37","doi-asserted-by":"crossref","unstructured":"Izumiyama K, Nakagawa M, Yonezumi M, et al. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18)(q21;q21) MALT lymphoma. Oncogene\u20082003; 22: 8085\u201392.","DOI":"10.1038\/sj.onc.1207002"},{"key":"2022061621042586000_B38","doi-asserted-by":"crossref","unstructured":"Hosokawa Y, Suzuki H, Nakagawa M, Lee TH, Seto M. API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-\u03baB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-\u03baB activation. Biochem Biophys Res Commun\u20082005; 334: 51\u201360.","DOI":"10.1016\/j.bbrc.2005.06.058"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/10\/5270\/2548442\/5270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/10\/5270\/2548442\/5270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T18:22:17Z","timestamp":1655403737000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/10\/5270\/525582\/Selective-Expansion-of-Marginal-Zone-B-Cells-in-E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,15]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2006,5,16]]},"published-print":{"date-parts":[[2006,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-4590","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22365449.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22365452","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22365449","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22365452.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22365446.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22365446","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494708","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494708.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,15]]}}}